Business · 28/07/2016
FDA Establishes Public Docket for Blood Donor Deferral Policy Comments
The FDA is seeking public comments on its revised blood donor deferral recommendations to reduce HIV transmission risk, with a focus on alternative deferral options and study design.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →